Results 251 to 260 of about 141,167 (306)

Survival benefit of extended lymphadenectomy in endometrial cancer: a meta-analysis with risk-stratified subgroup analysis. [PDF]

Front Oncol
Fan Y, Zhu J, Jiang L, Xu J, Huang J.
europepmc   +1 more source

Immunotherapy in Endometrial Cancer: Molecular Classification, Clinical Evidence, and Therapeutic Implications: A Narrative Review. [PDF]

Cancers (Basel)
Padilla-Iserte P, Cabrera S, Gatius Calderó S, de Juan Ferré A, Majercakova K, Rubio-Pérez MJ, Romero I, Barretina-Ginesta MP, Orpinell MB.   +8 more
europepmc   +1 more source

Label-free quantitative urinary proteomics for non-invasive biomarker discovery in endometrial cancer. [PDF]

Front Med (Lausanne)
Akkour K, Rafiullah M, Masood A, Alanazi IO, Alfadda AA, Joy SS, Bassi A, Alhalal H, Alshehri E, Arafah M, Nawaz S, Benabdelkamel H.   +11 more
europepmc   +1 more source

MLH1 promoter methylation-induced dMMR/MSS in endometrial cancer: case report. [PDF]

Discov Oncol
Qu Z, Mao J, Zhang X, Xiang L.
europepmc   +1 more source

Serum human epididymis protein 4, endocan, sialyl-Tn, and neopterin in endometrial cancer: a prospective case-control study. [PDF]

Rev Assoc Med Bras (1992)
Toyran A, Minareci Y, Sözen H, Kucukgergin C, Aydın AF, Bingul İ, Gunver MG, Akkoyunlu SZ, Topuz S, Salihoglu MY.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Endometrial Cancer

Obstetrical & Gynecological Survey, 2020
(Abstracted from N Engl J Med 2020;383:2053–2064) Incidence rates and associated mortality of endometrial cancer continue to rise in the United States, including a sustained rise in cases among women younger than 50 years. This trend is partially driven by the rising rates of obesity, one of the most important risk factors for this disease.
Karen H, Lu, Russell R, Broaddus
openaire   +2 more sources